Page last updated: 2024-09-04

irofulven and illudin m

irofulven has been researched along with illudin m in 2 studies

Compound Research Comparison

Studies
(irofulven)
Trials
(irofulven)
Recent Studies (post-2010)
(irofulven)
Studies
(illudin m)
Trials
(illudin m)
Recent Studies (post-2010) (illudin m)
992271808

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biersack, B; Knauer, S; Ocker, M; Schobert, R1
Dick, RA; Kensler, TW; Yu, X1

Other Studies

2 other study(ies) available for irofulven and illudin m

ArticleYear
Conjugates of the fungal cytotoxin illudin M with improved tumour specificity.
    Bioorganic & medicinal chemistry, 2008, Sep-15, Volume: 16, Issue:18

    Topics: Agaricales; Cell Line, Tumor; Chlorambucil; Colonic Neoplasms; Cytotoxins; Dicarboxylic Acids; Docosahexaenoic Acids; Esters; Fibroblasts; Humans; Pancreatic Neoplasms; Polycyclic Sesquiterpenes; Sesquiterpenes; Structure-Activity Relationship; Toxicity Tests

2008
NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2004, Feb-15, Volume: 10, Issue:4

    Topics: Alcohol Oxidoreductases; Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Agents; Cell Line; Cell Line, Tumor; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Glutathione; Humans; Ketones; Kinetics; Mass Spectrometry; Models, Chemical; Polycyclic Sesquiterpenes; Sensitivity and Specificity; Sesquiterpenes; Time Factors; Transfection

2004